Search results for: 'analyzer ad cems'

This research service analyzes the market for clinical laboratory analyzers within the United States. The United States market was divided into the clinical chemistry, immunoassay, integrated, hematology, hemostasis, and blood gas analyzer market segments. Each segment of this service covers market drivers, market restraints, competitive structur...

This research study examines the hearing instruments and ABR and OAE analyzers markets in the U.S. in 2005. The objective of this study is to evaluate the present state of these markets and present a forecast and analysis of the units, pricing and revenues. The forecast period is from 2006 to 2012, with a base year of 2005. The segment also identi...

06 May 2016  |  Asia Pacific  |  Market Research

Global Generic Pharmaceuticals Market, Forecast to 2020

Market Participants Target High Value-added Branded Generics and Biosimilars Segments

Infographics

×

The key objectives of this research service are to gain an in-depth knowledge of the major markets and therapeutic areas and organizations presenting significant growth opportunities for generics, to understand the impact of regulation on the market, and to outline the industry consolidation trends that will continue shaping the future of generics....

Artificial intelligence (AI) is exhibiting real promise across multiple industries. The healthcare industry is leading the charge when it comes to focused AI application development and attracting AI investment globally. With improvements in healthcare data acquisition and computing power, AI is becoming more of a reality each day. Frost & Sullivan...

The research service primarily encompasses comprehensive analyses of key emerging therapies across AD and PD.The service includes treatment overviews, emerging therapeutic platforms, IP and funding analysis, and emerging innovation profiles across Alzheimer's and Parkinson's diseases. Furthermore, the research service features the impact of key t...

This Frost Radar benchmarks companies offering digital pathology solutions for hospitals and laboratories and discusses opportunities in clinical, pharma, CRO, and research applications. Digital pathology solutions cover all aspects of workflow including sample collection and preparation, image acquisition and integrated image storage, and anal...

The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...

Medical device connectivity (MDC) refers to the integration of medical devices across various care settings with health information systems, enabling the seamless exchange of patient data. Connectivity is established through wired (e.g., USB and Ethernet) and wireless (e.g., Wi-Fi and Bluetooth) networks, with the primary goal of minimizing manual ...

Pharmaceutical companies spend billions of dollars in drug development because of expensive and time-consuming clinical trials, with a meager success rate. Frequent clinical visits, manual data processing, and a lack of consistent data on the effectiveness of the investigation of medical products contribute to their low success rate. Digital bio...